Bio-Techne (TECH) Other Non Operating Income (2009 - 2026)
Bio-Techne (TECH) posted quarterly Other Non Operating Income of -$160000.0 for Q1 2026, up 90.66% year-over-year from -$83919.2 in Q1 2025, and up 77.5% quarter-over-quarter from -$711000.0 in Q4 2025.
Bio-Techne (TECH) Other Non Operating Income (2009 - 2026) Analysis & Trends
Bio-Techne's Other Non Operating Income history runs 18 years deep, the most recent figure standing at -$160000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 90.66% year-over-year to -$160000.0; the TTM figure through Mar 2026 stood at $3.1 million (up 131.81% YoY), while the FY2025 annual figure was $831000.0, up 109.68% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$160000.0, up from -$711000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $7.2 million in Q1 2022, with the low at -$4.9 million in Q2 2024.
- The 5-year median for Other Non Operating Income is -$350000.0 (2023), against an average of $247058.8.
- Peak annual rise in Other Non Operating Income reached 214.64% in 2025, while the deepest fall reached 1480.0% in 2025.
- Bio-Techne's Other Non Operating Income stood at -$685000.0 in 2022, then plunged by 435.77% to -$3.7 million in 2023, then jumped by 98.77% to -$45000.0 in 2024, then plunged by 1480.0% to -$711000.0 in 2025, then surged by 77.5% to -$160000.0 in 2026.
- Business Quant data shows TECH's Other Non Operating Income at -$160000.0 in Q1 2026, -$711000.0 in Q4 2025, and -$1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -160,000.00 |
| Dec 31, 2025 | -711,000.00 |
| Sep 30, 2025 | -1.67 Mn |
| Jun 30, 2025 | 5.62 Mn |
| Mar 31, 2025 | -1.71 Mn |
| Dec 31, 2024 | -45,000.00 |
| Sep 30, 2024 | -3.03 Mn |
| Jun 30, 2024 | -4.90 Mn |
| Mar 31, 2024 | 335,000.00 |
| Dec 31, 2023 | -3.67 Mn |
| Sep 30, 2023 | -350,000.00 |
| Jun 30, 2023 | 2.49 Mn |
| Mar 31, 2023 | -1.71 Mn |
| Dec 31, 2022 | -685,000.00 |
| Sep 30, 2022 | 4.70 Mn |
| Jun 30, 2022 | 2.52 Mn |
| Mar 31, 2022 | 7.18 Mn |
| Dec 31, 2021 | 26.49 Mn |
| Sep 30, 2021 | 7.38 Mn |
| Jun 30, 2021 | 1.57 Mn |